261637-72-3

Basic information

• Product Name: 1-(3-METHOXYBENZYL)-1H-INDOLE-3-CARBALDEHYDE
• Synonyms: 1-(3-METHOXYBENZYL)-1H-INDOLE-3-CARBALDEHYDE;1-(3-methoxybenzyl)-1H-indole-3-carbaldehyde(SALTDATA: FREE);1-(3-methoxybenzyl)indole-3-carbaldehyde;1-[(3-methoxyphenyl)methyl]-3-indolecarboxaldehyde;1-[(3-methoxyphenyl)methyl]indole-3-carbaldehyde;IVK/4021695
• CAS NO: 261637-72-3
• Molecular Formula: C17H15NO2
• Molecular Weight: 265.31
• Mol File: 261637-72-3.mol

Chemical Properties

• Boiling Point: 473.8°C at 760 mmHg
• Flash Point: 240.4°C
• Appearance: /
• Density: 1.13g/cm³
• Vapor Pressure: 3.81E-09mmHg at 25°C
• Refractive Index: 1.591
• CAS DataBase Reference: 1-(3-METHOXYBENZYL)-1H-INDOLE-3-CARBALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(3-METHOXYBENZYL)-1H-INDOLE-3-CARBALDEHYDE(261637-72-3)
• EPA Substance Registry System: 1-(3-METHOXYBENZYL)-1H-INDOLE-3-CARBALDEHYDE(261637-72-3)

Safety Data

• Hazardous Substances Data: 261637-72-3(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
1-(3-Methoxybenzyl)-1H-indole-3-carbaldehyde is used as a key intermediate in organic synthesis for the production of various organic compounds. Its aromatic and aldehyde groups facilitate the formation of new chemical bonds and reactions, making it a versatile component in the synthesis of complex organic molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 1-(3-Methoxybenzyl)-1H-indole-3-carbaldehyde is used as a building block for the development of new pharmaceuticals. Its unique structure allows for selective interactions with biological targets, which can be exploited to design drugs with specific therapeutic effects.
Used in Medicinal Chemistry:
1-(3-Methoxybenzyl)-1H-indole-3-carbaldehyde is utilized in medicinal chemistry as a valuable component for the creation of novel drug candidates. Its potential for selective binding to biological targets makes it an attractive starting point for the design and optimization of new therapeutic agents.

InChI:InChI=1/C17H15NO2/c1-20-15-6-4-5-13(9-15)10-18-11-14(12-19)16-7-2-3-8-17(16)18/h2-9,11-12H,10H2,1H3

Upstream product

• 487-89-8 Indole-3-carboxaldehyde 
• 874-98-6 1-bromomethyl-3-methoxybenzene 

Relevant articles and documents

Synthesis, antimycobacterial and anticancer activity of novel indole-based thiosemicarbazones

Based on the structural elements of bioactive indole-based compounds, a series of novel 1-substituted indole-3-carboxaldehyde thiosemicarbazones were synthesized as potential antimycobacterial and anticancer agents. The derivatives were prepared via a two

Design, synthesis and biological evaluation of matrine derivatives as potential anticancer agents

Using matrine (1) as the lead compound, a series of new 14-(N-substituted-2-pyrrolemethylene) matrine and 14-(N-substituted-indolemethylene) matrine derivatives was designed and synthesized for their potential application as anticancer agents. The structure of these compounds was characterized by 1H NMR, 13C NMR and ESI-MS spectral analyses. The target compounds were evaluated for their in vitro cytotoxicity against three human cancer cell lines (SMMC-7721, A549 and CNE2). The results revealed that compound A6 and B21 displayed the most significant anticancer activity against three cancer cell lines with IC50 values in range of 3.42–8.05 μM, which showed better activity than the parent compound (Matrine) and positive control Cisplatin. Furthermore, the Annexin V-FITC/PI dual staining assay revealed that compound A6 and B21 could significantly induce the apoptosis of SMMC-7721 and CNE2 cells in a dose-dependent manner. The cell cycle analysis also revealed that compound A6 could cause cell cycle arrest of SMMC-7721 and CNE2 cells at G2/M phase.

B-ring modified aurones as promising allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase

Following our recent report showing the potential of naturally occurring aurones (2-benzylidenebenzofuran-3(2H)-ones) as anti-hepatitis C virus (HCV) agents, efforts were continued in order to refine the structural requirements for the inhibitory effect on HCV RNA-dependent RNA polymerase (RdRp). In this study, we targeted the B-ring moiety of aurones with the aim to improve structural features associated with higher inhibition of the targeted polymerase. In vitro evaluation of the RdRp inhibitory activity of the 37 newly synthesized compounds pointed out that the replacement of the B-ring with an N-substituted indole moiety induced the highest inhibitory effect. Of these, compounds 31, 40 and 41 were found to be the most active (IC50 = 2.3-2.4 μM). Docking experiments performed with the most active compounds revealed that the allosteric thumb pocket I of RdRp is the binding pocket for aurone analogues.